Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial

Yan Jiang,1,* Zhen-Lin Zhang,2,* Zhong-Lan Zhang,3 Han-Min Zhu,4 Yi-Yong Wu,5 Qun Cheng,4 Feng-Li Wu,5 Xiao-Ping Xing,1 Jian-Li Liu,3 Wei Yu,6 Xun-Wu Meng11Department of Endocrinology, Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijin...

Full description

Bibliographic Details
Main Authors: Jiang Y, Zhang ZL, Zhu HM, Wu YY, Cheng Q, Wu FL, Xing XP, Liu JL, Yu W, Meng XW
Format: Article
Language:English
Published: Dove Medical Press 2014-01-01
Series:Clinical Interventions in Aging
Subjects:
menatetrenone
alfacalcidol
postmenopausal
osteoporosis
mineral bone density
undercarboxylated osteocalcin
Online Access:https://www.dovepress.com/menatetrenone-versus-alfacalcidol-in-the-treatment-of-chinese-postmeno-peer-reviewed-article-CIA

Internet

https://www.dovepress.com/menatetrenone-versus-alfacalcidol-in-the-treatment-of-chinese-postmeno-peer-reviewed-article-CIA

Similar Items